<DOC>
	<DOCNO>NCT02211118</DOCNO>
	<brief_summary>A variety medication use treat anxiety , discomfort , fear associate continuous sudden episodic breathlessness patient advance respiratory disease . Opioids benzodiazepine , use alone combination , commonly prescribe distress symptom . Clinicians concerned adverse effect opioids , especially respiratory depression , frequently prescribe benzodiazepine . Recent study show benzodiazepine use associate increased adverse respiratory outcome older adult Chronic Obstructive Pulmonary Disease ( COPD ) . Dexmedetomidine may alternative current drug therapy breathlessness . Dexmedetomidine produce dose dependent sedation , anxiolysis , analgesia without respiratory depression cognitive dysfunction . The drug administer intranasally induce light moderate sedation several hour duration . The objective propose research , pilot study , assess dose dependent safety efficacy intranasal dexmedetomidine clinically stable patient severe COPD . This accomplish staffed acute care set routine vital sign monitor pulse oximetry . Patients assess objectively subjectively level sedation validate sedation scale . This pilot study initial investigation drug favorable pharmacologic property patient population distress difficult treat symptom . The pilot study may provide evidence large trial need confirm study result , evidence additional study symptomatic patient treatment comparison trial pursue .</brief_summary>
	<brief_title>Sedation Physiological Effects Intranasal Dexmedetomidine Severe COPD</brief_title>
	<detailed_description />
	<mesh_term>Dexmedetomidine</mesh_term>
	<criteria>Severe COPD ( FEV1 3050 % predict ) Age 4570 American Society Anesthesiologists ( ASA ) Class 3 Body Mass Index &lt; 35 kg/meter square No prior history adverse reaction alpha 2 agonist ( dexmedetomidine , clonidine ) Women nonchild bearing age know adverse reaction , allergy hypersensitivity , alpha 2 agonist nothing mouth ( NPO ) ASA class &gt; 3 Home oxygen therapy &gt; 2LPM nasal cannula continuous use Any evidence nasal mucosal inflammation , irritation , bleed ulceration Pregnancy , possibility pregnancy Coronary heart disease stable unstable angina Baseline heart rate &lt; 55 beat per minute Bradyarrhythmia , heart block , presence pacemaker Congestive Heart Failure know Cardiomyopathy ( Ejection Fraction &lt; 40 % ECHO , MUGA , myocardial perfusion image ) Cor pulmonale Liver disease ( hepatic transaminase upper limit normal , cirrhosis , end stage liver disease ) diagnosis moderate severe Obstructive Sleep Apnea currently enrol research study involve drug device</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>